stockrowPalvella Therapeutics, Inc. (PVLA) vs Recursion Pharmaceuticals, Inc. (RXRX)
- Palvella Therapeutics, Inc. PVLA 172.38 +9.90%
- Recursion Pharmaceuticals, Inc. RXRX 3.58 +2.29%
Palvella Therapeutics, Inc. and Recursion Pharmaceuticals, Inc. are both Biotechnology companies. Palvella Therapeutics, Inc. and Recursion Pharmaceuticals, Inc. are of similar size ($2.3B and $2.2B). Palvella Therapeutics, Inc. grew revenue faster over the last twelve months: 146.7% against 56.2%. Palvella Therapeutics, Inc. has the higher net margin (0.00% vs −697.1%) and the higher return on invested capital (0.00% vs −88.5%). Across the 18 metrics below, Palvella Therapeutics, Inc. leads on 12 and Recursion Pharmaceuticals, Inc. on 6.
Valuation
Profitability
| Metric | PVLA | RXRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 29.21% | 65.16% |
| Operating margin | 0.00% | (725.44%) | 0.00% |
| Net margin | 0.00% | (697.13%) | 0.00% |
| Free cash flow margin | 0.00% | (460.89%) | 0.00% |
| Return on equity | (46.63%) | (48.72%) | (50.12%) |
| Return on assets | (37.70%) | (36.29%) | (45.60%) |
| Return on invested capital | 0.00% | (88.54%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack